Royal College of General Practitioners guidance places significant doubt on consumer genetic testing.
Consumer interest in genetic testing has grown in popularity in recent years,...
Trouble in paradise? Or extra funding for new goals in precision health analytics?
The abrupt press announcement on the Human Longevity, Inc. website was one...
UK start-up Ervaxx targets 'dark matter' genes to develop cell therapies.
After two years in stealth mode, the new UK-based start-up Ervaxx has stepped out of...
Israeli start-up bags $5 million Series A to drive development of new AI models.
Like London buses, we write about one company using artificial intelligence...
Accessible technology firm, already partnering with Samsung, raising funds to make smartphones easier to use for older users.
We are pleased to announce the start...
Applications open for the Longevity Leaders World Congress start-up showcase.
The Longevity sector is in part characterised by the emergence of two exciting classes of...
The Copenhagen biotech's acquisition of Encycle Therapeutics demonstrates growing market interest in peptide-based drugs.
Zealand Pharma, a Copenhagen-based biotech company focused on the development of...
An exclusive with AgeX Therapeutics CEO Dr Michael West looks at the puzzle of aging.
AgeX Therapeutics is an American biotechnology developing novel therapeutics that...
Royal College of General Practitioners guidance places significant doubt on consumer genetic testing.
Consumer interest in genetic testing has grown in popularity in recent years,...
New IoT device focuses on prolonging independence for the broader aging population.
While there are many technologies out there designed to help older people who...
